Ozairi EA, Taghadom E, Irshad M, Yousef AA, et al. Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m(2), and chronic kidney disease - A randomised, controlled pilot study. Diabetes Res Clin Pract 2026;231:113066.
PMID: 41435968